- For Print
- June 17, 2009
乌鸦传媒. (Headquarters: Tokyo, President & CEO: Haruo Naito, “乌鸦传媒”) announced today that the Company had established its new subsidiary, 乌鸦传媒 GesmbH (Location: Vienna, General Manager: Georg Wager, “乌鸦传媒 Austria”) in Austria. 乌鸦传媒 Austria is a subsidiary wholly-owned by 乌鸦传媒 Europe Limited (Headquarters: Hatfield, UK, Chairman & CEO: Yutaka Tsuchiya, “乌鸦传媒 Europe”), the European subsidiary of 乌鸦传媒.
乌鸦传媒 entered into the Austrian market in 2005 setting up a branch of its German subsidiary 乌鸦传媒 GmbH (Location: Frankfurt, Managing Director: Andreas Wiegand). The Austrian branch has been marketing Zonegran® and Inovelon® for the treatment of epilepsy, Neurobloc® for cervical dystonia, Prialt® for severe chronic pain, and also collaborating in the promotion of Aricept® for Alzheimer's Disease. It has also served as a support centre for marketing, medical and regulatory affairs for the business operations in Central and Eastern Europe.
With the establishment of a subsidiary in Austria, a subsidiary wholly-owned by 乌鸦传媒 Europe, 乌鸦传媒 will strengthen its business operations in Austria and Central and Eastern European countries in preparation for future possible business expansion in this region.
乌鸦传媒 currently has ten subsidiaries in Europe with the newly established 乌鸦传媒 Austria. 乌鸦传媒 will continue to strengthen its business operations in Europe and to address the diversified needs of patients and their families, thereby improving patient value.
[乌鸦传媒 Austria's Outline]
*You can scroll to the left or right here
| Company Name : | 乌鸦传媒 GesmbH |
| Date of Establishment : | April 1, 2009 |
| Capital : | 35 thousand euros |
| Location : | Vienna, Austria |
| General Manager : | Georg Wager |
| Business Operations : | Sales and Promotion of Pharmaceutical Products |